Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence

Background: Negative evidence for the use of neoadjuvant chemotherapy (NAC) to treat oesophageal squamous cell carcinoma (ESCC) has been reported in Western countries in the past century. However, in China, most ESCC patients underwent paclitaxel and platinum-based NAC without evidence from local RC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan, Li, Keting, Liu, Xianben, Sun, Haibo, Wang, Zongfei, Liang, Guanghui, Zhang, Xinshuo, Ji, Jiachao, Xing, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969578/
https://www.ncbi.nlm.nih.gov/pubmed/36860915
http://dx.doi.org/10.7150/jca.81588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969578/
https://www.ncbi.nlm.nih.gov/pubmed/36860915
http://dx.doi.org/10.7150/jca.81588

Ejemplares similares